MARKET

ISPC

ISPC

Ispecimen Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.365
+0.035
+1.49%
Opening 11:38 06/29 EDT
OPEN
2.360
PREV CLOSE
2.330
HIGH
2.400
LOW
2.330
VOLUME
10.36K
TURNOVER
14.13K
52 WEEK HIGH
28.98
52 WEEK LOW
2.070
MARKET CAP
20.85M
P/E (TTM)
-2.4119
1D
5D
1M
3M
1Y
5Y
An Intrinsic Calculation For iSpecimen Inc. (NASDAQ:ISPC) Suggests It's 47% Undervalued
Does the June share price for iSpecimen Inc. ( NASDAQ:ISPC ) reflect what it's really worth? Today, we will estimate...
Simply Wall St. · 06/08 12:49
BRIEF-Ispecimen Appoints Evan Cox As Vice President Of Product Management
reuters.com · 06/08 12:27
iSpecimen Appoints Evan Cox as Vice President of Product Management
Industry Veteran Brings Nearly Two Decades of Experience in Healthcare Product Management to the CompanyLEXINGTON, Mass., June 08, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that conn...
GlobeNewswire · 06/08 11:30
iSpecimen Presents New Research to Optimize Biobanking at International Society for Biological and Environmental Repositories 2022 Annual Meeting
Company Gave Three Presentations, Including Oral Discussion on How New Technology Can Support the “Just-in-Time” Approach to Biobanking LEXINGTON, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ: ISPC) (“iSpecimen” or the “Company”), a globa...
GlobeNewswire · 05/19 11:30
iSpecimen to Participate in the H.C. Wainwright Global Investment Conference on May 23-26, 2022
LEXINGTON, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen provid...
GlobeNewswire · 05/16 11:30
iSpecimen GAAP EPS of -$0.27, revenue of $2.5M
iSpecimen press release (NASDAQ:ISPC): Q1 GAAP EPS of -$0.27. Revenue of $2.5M. The reduction in revenue during the quarter was primarily due to the Russia and Ukraine conflict that shut down supply sites in
Seekingalpha · 05/10 12:07
iSpecimen Q1 EPS $(0.27) Up From $(4.23) YoY, Sales $2.50M Miss $2.55M Estimate
iSpecimen (NASDAQ:ISPC) reported quarterly losses of $(0.27) per share. This is a 93.62 percent increase over losses of $(4.23) per share from the same period last year. The company reported quarterly sales of $2.50
Benzinga · 05/10 11:50
-- Earnings Flash (ISPC) ISPECIMEN Posts Q1 Revenue $2.5M, vs. Street Est of $2.72M
MT Newswires · 05/10 07:18
More
No Data
Learn about the latest financial forecast of ISPC. Analyze the recent business situations of Ispecimen Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average ISPC stock price target is 11.08 with a high estimate of 17.00 and a low estimate of 6.25.
High17.00
Average11.08
Low6.25
Current 2.365
EPS
Actual
Estimate
-0.22-0.16-0.11-0.05
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 13
Institutional Holdings: 310.76K
% Owned: 3.52%
Shares Outstanding: 8.82M
TypeInstitutionsShares
Increased
5
78.13K
New
6
107.54K
Decreased
2
331.02K
Sold Out
6
703.87K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
No Data
About ISPC
iSpecimen Inc. is a technology-driven company. The Company designed iSpecimen Marketplace platform to transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. The Company’s marketplace platform ingests de-identified healthcare data provided by healthcare supply partners. The iSpecimen Marketplace supports the supply chain management and bioprocurement process for specimens and associated data. The Company’s platform helps with administrating and reporting function for researchers, suppliers, and internal personnel, including user and compliance management. The Company serves to biopharmaceutical companies, in vitro diagnostic (IVD) companies, and government/academic institutions.

Webull offers kinds of iSpecimen Inc stock information, including NASDAQ:ISPC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ISPC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ISPC stock methods without spending real money on the virtual paper trading platform.